Stephen J. Gongaware, MSA EVP, Business Development presented a poster in March at the Emerald Conference in San Diego highlighting some innovative work the MSA Cannabis R&D team is doing to understand the impact on medical cannabis consumption on health outcomes. The Pittsburgh Business Times recently ran an article on this innovative work that builds upon MSA Life Sciences Division’s multi-patented de-identification technology. Click here to read the article.